257 related articles for article (PubMed ID: 8309316)
1. Ocular effects of topical administration of the phosphodiesterase III inhibitor milrinone in rabbits and cats.
Lee KC; Silver PJ; Bode DC; Gherezghiher T
Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):527-34. PubMed ID: 8309316
[TBL] [Abstract][Full Text] [Related]
2. Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors.
Ogidigben MJ; Chu TC; Potter DE
Exp Eye Res; 2001 Mar; 72(3):331-9. PubMed ID: 11180982
[TBL] [Abstract][Full Text] [Related]
3. Nitrovasodilators as a new class of ocular hypotensive agents.
Nathanson JA
J Pharmacol Exp Ther; 1992 Mar; 260(3):956-65. PubMed ID: 1532035
[TBL] [Abstract][Full Text] [Related]
4. Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys.
Tokushige H; Inatani M; Nemoto S; Sakaki H; Katayama K; Uehata M; Tanihara H
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3216-22. PubMed ID: 17591891
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
Bivalacqua TJ; Champion HC; Rajasekaran M; Sikka SC; Kadowitz PJ; Doherty PC; Hellstrom WJ
J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946
[TBL] [Abstract][Full Text] [Related]
6. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist.
Russell KR; Wang DR; Potter DE
Exp Eye Res; 2000 May; 70(5):675-82. PubMed ID: 10870526
[TBL] [Abstract][Full Text] [Related]
7. The effect of intravitreal and topical prostaglandins on intraocular inflammation.
Kulkarni PS; Srinivasan BD
Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):383-92. PubMed ID: 7050005
[TBL] [Abstract][Full Text] [Related]
8. The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes.
Nishio M; Fukunaga T; Sugimoto M; Ikesugi K; Sumi K; Hidaka H; Uji Y
Curr Eye Res; 2009 Apr; 34(4):282-6. PubMed ID: 19373576
[TBL] [Abstract][Full Text] [Related]
9. Contributions of adenosine receptor activation to the ocular actions of epinephrine.
Crosson CE; Petrovich M
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2054-61. PubMed ID: 10440261
[TBL] [Abstract][Full Text] [Related]
10. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
Brechue WF; Maren TH
Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
[TBL] [Abstract][Full Text] [Related]
11. Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys.
Gabelt BT; Robinson JC; Hubbard WC; Peterson CM; Debink N; Wadhwa A; Kaufman PL
Exp Eye Res; 1994 Dec; 59(6):633-44. PubMed ID: 7698258
[TBL] [Abstract][Full Text] [Related]
12. Effects of systemic administration of 0.5% tropicamide on intraocular pressure, pupillary diameter, blood pressure, and heart rate in normal cats.
Schmidt KS; Hacker DV; Kass PH; Barkhoodarian AL
Vet Ophthalmol; 2006; 9(2):137-9. PubMed ID: 16497239
[TBL] [Abstract][Full Text] [Related]
13. Myocardial effects of cyclic AMP phosphodiesterase inhibition are dampened in thyroxine-induced cardiac hypertrophy.
Straznicka M; Leone RJ; Scholz PM; Weiss HR
J Surg Res; 1998 Apr; 76(1):61-6. PubMed ID: 9695741
[TBL] [Abstract][Full Text] [Related]
14. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
Stadtbäumer K; Frommlet F; Nell B
Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582.
Pagani ED; Dundore RL; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
J Cardiovasc Pharmacol; 1994 Sep; 24(3):403-10. PubMed ID: 7528296
[TBL] [Abstract][Full Text] [Related]
16. Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion.
Chiu T; Reid IA
J Pharmacol Exp Ther; 1996 Aug; 278(2):793-9. PubMed ID: 8768733
[TBL] [Abstract][Full Text] [Related]
17. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal cats.
Miller PE; Rhaesa SL
Am J Vet Res; 1996 Jan; 57(1):83-6. PubMed ID: 8720244
[TBL] [Abstract][Full Text] [Related]
18. Ocular effects of topical 0.03% bimatoprost solution in normotensive feline eyes.
Regnier A; Lemagne C; Ponchet A; Cazalot G; Concordet D; Gelatt KN
Vet Ophthalmol; 2006; 9(1):39-43. PubMed ID: 16409244
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs.
Lee KC; Clas DM; Gorczyca WP; Silver PJ; Ezrin AM
Drugs Exp Clin Res; 1991; 17(7):323-36. PubMed ID: 1686584
[TBL] [Abstract][Full Text] [Related]
20. Iloprost, a stable prostacyclin analog, reduces intraocular pressure.
Hoyng PF; de Jong N
Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):470-6. PubMed ID: 2435669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
